M.R.C.P. F.R.C.R. Alan Jackson Ph.D.

  • Citations Per Year
Learn More
Solitary myeloma of bone is a form of plasma cell tumor, histologically indistinguishable from multiple myeloma but characterised by a single bony focus of disease. Most patients respond to local radiotherapy (median survival 10–12 years); however, many (>30%) rapidly develop multiple myeloma (median survival 2–4 years). Currently, no criteria exist for(More)
  • 1